Sunday, October 05, 2014 4:14:23 PM
I'm always surprised by those who think institutions have God-like powers of discernment. Enron had institutional investors.
Yes, some of those institutions have smart guys. So? Some of the bulls here are smart guys, and so are some of the detractors. I doubt very much that the analysts at the institutions know any more about NNVC than the public knowledge that the people here know. The important thing to keep in mind is that none of those institutions have anywhere near as high a percentage of their total portfolio invested in NNVC as the typical bull on this board. So if NNVC fails many of the people on this board will be hurting badly while all of those institutions will keep sailing along.
Yes, some of those institutions have smart guys. So? Some of the bulls here are smart guys, and so are some of the detractors. I doubt very much that the analysts at the institutions know any more about NNVC than the public knowledge that the people here know. The important thing to keep in mind is that none of those institutions have anywhere near as high a percentage of their total portfolio invested in NNVC as the typical bull on this board. So if NNVC fails many of the people on this board will be hurting badly while all of those institutions will keep sailing along.
Recent NNVC News
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:07:54 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2025 08:33:17 PM
